Wednesday, June 6, 2012

A Phase 1/Phase 2 Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke

The actual trials I blogged about. Note the term chronic. If your doctor doesn't know about this, ask why.  Consult your doctor before joining.
Previous post;
http://oc1dean.blogspot.com/2012/05/acorda-therapeutics-presents.html

Recruitment here: Florida, Georgia, Virginia
http://www.clinicaltrials.gov/ct2/show/NCT01605825?term=Acorda&rank=4

No comments:

Post a Comment